首页> 外文期刊>Biochimica et biophysica acta. Bioenergetics >Identification by site-directed mutagenesis of a hydrophobic binding site of the mitochondrial carnitine/acylcarnitine carrier involved in the interaction with acyl groups
【24h】

Identification by site-directed mutagenesis of a hydrophobic binding site of the mitochondrial carnitine/acylcarnitine carrier involved in the interaction with acyl groups

机译:通过定点诱变鉴定参与与酰基相互作用的线粒体肉碱/酰基肉碱载体的疏水结合位点

获取原文
获取原文并翻译 | 示例
           

摘要

The role of hydrophobic residues of the mitochondrial carnitine/ acylcarnitine carrier (CAC) in the inhibition by acylcarnitines has been investigated by site-directed mutagenesis. According to the homology model of CAC in cytosolic opened conformation (c-state), L14, G17, G21, V25, P78, V82, M85, C89, F93, A276, A279, C283, F287 are located in the 1st (H1), 2nd (H2) and 6th (H6) transmembrane α-helices and exposed in the central cavity, forming a hydrophobic half shell. These residues have been substituted with A (or G) and in some cases with M. Mutants have been assayed for transport activity measured as [ 3H]carnitine/carnitine antiport in proteoliposomes. With the exception of G17A and G21M, mutants exhibited activity from 20% to 100% of WT. Among the active mutants only G21A, V25M, P78A and P78M showed Vmax lower than half and/or Km more than two fold respect to WT. Acylcarnitines competitively inhibited carnitine antiport. The extent of inhibition of the mutants by acylcarnitines with acyl chain length of 2, 4, 8, 12, 14 and 16 has been compared with the WT. V25A, P78A, P78M and A279G showed reduced extent of inhibition by all the acylcarnitines; V25M showed reduced inhibition by shorter acylcarnitines; V82A, V82M, M85A, C89A and A276G showed reduced inhibition by longer acylcarnitines, respect to WT. C283A showed increased extent of inhibition by acylcarnitines. Variations of Ki of mutants for acylcarnitines reflected variations of the inhibition profiles. The data demonstrated that V25, P78, V82, M85 and C89 are involved in the acyl chain binding to the CAC in c-state.
机译:通过定点诱变研究了线粒体肉碱/酰基肉碱载体(CAC)的疏水残基在抑制酰基肉碱中的作用。根据CAC的胞质开放构象(c状态)同源模型,L14,G17,G21,V25,P78,V82,M85,C89,F93,A276,A279,C283,F287位于第一个(H1) ,第二(H2)和第六(H6)跨膜α螺旋并暴露在中心腔中,形成疏水的半壳。这些残基已被A(或G)取代,在某些情况下被M取代。已经测定了突变体的转运活性,以蛋白脂质体中的[3H]肉碱/肉碱逆转运为指标。除G17A和G21M以外,突变体的WT活性为20%至100%。在活性突变体中,仅G21A,V25M,P78A和P78M表现出的Vmax低于野生型的一半,和/或Km超过野生型的两倍。酰基肉碱竞争性地抑制肉碱的反转运。已经将酰基肉碱的酰基链长度为2、4、8、12、14和16的酰基肉碱对突变体的抑制程度与WT进行了比较。 V25A,P78A,P78M和A279G表现出对所有酰基肉碱抑制作用的降低; V25M显示出较短的酰基肉碱抑制作用降低;相对于WT,V82A,V82M,M85A,C89A和A276G显示出更长的酰基肉碱抑制作用降低。 C283A显示出被酰基肉碱抑制的程度增加。酰基肉碱突变体Ki的变化反映了抑制谱的变化。数据表明,V25,P78,V82,M85和C89参与c态与CAC的酰基链结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号